Antioxidants in cardiovascular pathology;Les antioxydants en pathologie cardiovasculaire

Sang Thrombose Vaisseaux

Volumn 18, Issue 4, 2006, Pages 192-198

  Bonnefont Rousselot, Dominique ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Faculte de Pharmacie   (France)

Author keywords

Antioxidant; Atherosclerosis; Clinical trial; Oxidative stress; Oxidized lipoprotein; Vitamin

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; VITAMIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HEART PROTECTION; HUMAN; SECONDARY PREVENTION; SHORT SURVEY; VITAMIN SUPPLEMENTATION;

EID: 33744498645     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (29)

1. Stocker R, Keaney Jr. JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381-478.
2. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-36.
3. Bergt C, Pennathur S, Fu X, et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 2004; 101: 13032-7.
4. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53(suppl. 1): 326S-334S.
5. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337: 1-5.
6. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in post-menoposal women. N Engl J Med 1996; 334: 1156-62.
7. Levy AP, Gerstein HC, Miller-Lotan R, et al. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Diabetes Care 2004; 27: 2767.
8. Fang JC, Kinlay S, Beltrame J, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002; 359: 1108-13.
9. Salonen RM, Nyyssönen K, Kaikkonen J, et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study. Circulation 2003; 107: 947-53.
10. Keaney Jr. JF, Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J 1999; 13: 965-75.
11. Azzi A, Breyer I, Feher M, et al. J Nutr 2000; 130: 1649-52.
12. Ricciarelli R, Zingg JM, Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000; 102: 82-7.
13. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 2005; 16: 77-84.
14. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004; 109(suppl.III): (III-39-43).
15. Delbosc S, Morena M, Djouad F, Ledoucen C, Descomps B, Cristol JP. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J Cardiovasc Pharmacol 2002; 40: 611-7.
16. Laufs U, Gertz K, Dirnagl U, Bohm M, Nickenig G, Endres M. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 2002; 942: 23-30.
17. Rosenson RS. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis 2004; 173: 1-12.
18. Clarke R, Armitage J. Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials. Cardiovasc Drugs Ther 2002; 16: 411-5.
19. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 1583-92.
20. Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis. Annu Rev Nutr 1999; 19: 123-39.
21. Brennan ML, Anderson MM, Shih DM, et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 2001; 107: 419-30.
22. Gaziano J-M. Vitamin E and cardiovascular disease. Observational studies. Ann NYAcad Sci 2004; 1031: 280-91.
23. Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL, for the Nutrition Committee of the American Heart Association Council on Nutrition. Physical Activity, and Metabolism. Antioxidant vitamin supplements and cardiovascular disease. Circulation 2004; 110: 637-41.
24. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998; 392: 559.
25. Rhee SG. Redox signalling: hydrogen peroxide as intracellular messenger. Exp Mol Med 1999; 31: 53-9.
26. Williams KJ, Fischer EA. Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr Opin Clin Nutr Care 2005; 8: 139-46.
27. Jiang XC, Li Z, Liu R, et al. Phospholipid transfer protein deficiency impairs apolipoprotein-B secretion from hepatocytes by stimulating a proteolytic pathway through a relative deficiency of vitamin E and an increase in intracellular oxidants. J Biol Chem 2005; 280: 18336-40.
28. Soccio RE, Breslow J-L. Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol 2004; 24: 1150-60.
29. Miller III ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ. Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 42: 37-46.